Clinical Trials · NCT04305002
Exenatide Treatment in Parkinson's Disease
- Phase
- Phase 2
- Recruitment status
- Unknown
- Sponsor
- Center for Neurology, Stockholm
- Enrollment
- 60
- Start date
- Jan 2020
- Locations
- 1 site, Sweden
- Primary endpoint
- FDG-PET network analysis